ASCO® 2023 Insights: "Phase 1b/2 CARTITUDE-1 Study Final Results - Ciltacabtagene Autoleucel in Heavily Pretreated Patients With R/R MM" | VuMedi

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

10 seconds

Playback speed

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Phase 1b/2 CARTITUDE-1 Study Final Results - Ciltacabtagene Autoleucel in Heavily Pretreated Patients With R/R MM"

By Insights from 2023 ASCO® Annual Meeting FEATURING Yi Lin

By Insights from 2023 ASCO® Annual Meeting FEATURING Yi Lin

145 views

July 14, 2023

Comments 0

Login to view comments. Click here to Login